Risks associated with overuse or inappropriate dosages should be considered
2 Various GLP-1 (glucagon-like peptide-1) medications are available on the market, offering multiple options for patients
Its known for its healing abilities, particularly when it comes to tissue repair, reducing inflammation, and improving blood flow all of which are key for muscle recovery and growth
Every patient starts with a provider evaluation, not just a questionnaire, so the team can review your health history, weight goals, eligibility, and treatment options
As a result, we have seen changes in recommendations for these GLP-1s from second-line to first-line treatment in the ADA Standards of Care in Diabetes 2023 and updates to the ACC 2020 Guidelines for Novel Cardiovascular Risk Reduction in Patients with T2D